Icure corrects large shareholding report, sets previous stake at 39.34%

Icure Pharmaceutical filed a correction to a large-shareholding report due to a clerical error. Previous filings stated 24,287,115 shares (39.34%) and shares tied to contracts at 24,177,949 (39.16%). The latest filing shows holdings at 24,739,115 shares (40.07%), with an increase driven by adding a special related party, including shares held by an outside director.